Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age (vol 35, pg 809, 2021)
LEUKEMIA(2021)
关键词
Myeloma,Randomized controlled trials,Stem-cell research,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要